Virtual Science AI Launches Competitor Tracking Platform for Pharma

May 16, 2026
Virtual Science AI has launched Medical Competitor AI, a platform that uses artificial intelligence to analyze competitor medical activities and scientific narratives for pharmaceutical companies.

Virtual Science AI announced in a press release the launch of Medical Competitor AI, a new platform that applies artificial intelligence to track competitor medical activities and scientific narratives. The system is designed to support pharmaceutical companies in planning and executing asset launches.

The platform provides intelligence on competitor activities such as conference presentations, publications, and social engagement. It also analyzes how the scientific community responds to these activities, helping teams refine their own medical narratives and focus resources effectively.

Medical Competitor AI expands the company’s existing medical intelligence suite, which includes tools for integrated medical intelligence, social intelligence, and congress insights. The new product is already in use by several major pharmaceutical firms and is part of a planned series of releases addressing key intelligence needs in life sciences.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

05/16
United Imaging Presents Full Radiotherapy Portfolio at ESTRO 2026
05/16
Accuray and UW-Madison Sign 10-Year Research Agreement for Adaptive Cancer Therapy
05/15
Enlil Adds Eight MedTech Customers in Record First Quarter of 2026
05/15
Psynk AI Partners with Ocean View Psychiatric Hospital to Deploy AI Psychiatric Assistant
05/15
AI Screening for Childhood Blindness Begins in Mongolia

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like